Company / SG&A per Share
LivaNova SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$10.10
FY2025
5-year range
$8.38 / $10.86
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
#43 of 156
Health Care
What the data says
At $10.10, LivaNova's sg&a per share ranks #114 of 156 in the Health Care sector. SG&A per Share has increased for 3 consecutive years, from $8.38 in FY2022 to $10.10 in FY2025.
Based on SEC 10-K filings.
10.10 in FY2025 with a 5-year CAGR of +1.8%.
Increased from $9.38 to $10.10 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- +1.8%
- 10-Year CAGR
- -
Sector benchmark
#114 of 156 in Health CareTop 72% of 156This company $10.10 Sector average $11421.53
▼
-99.9% below sector average
Key checks
Key Insights
- LivaNova's sg&a per share has grown for 3 consecutive years.
- In FY2025, sg&a per share increased 7.0% year-over-year.
- Ranks #43 out of 156 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.10 | +7.0% |
| FY2024 | $9.44 | +0.6% |
| FY2023 | $9.38 | +11.9% |
| FY2022 | $8.38 | -22.8% |
| FY2021 | $10.86 | +17.8% |
| FY2020 | $9.22 | -15.9% |
| FY2019 | $10.96 | +13.8% |
| FY2018 | $9.63 | +121571.6% |
| FY2017 | $0.01 | -99.9% |
| FY2016 | $13.66 | +204.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026